Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunction

International Journal of Impotence Research

Volumn 20, Issue 6, 2008, Pages 537-543

  Thurtell, M J ^a   Tomsak, R L ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Erectile dysfunction; NAION; PDE 5 inhibitors; Visual loss

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL;

COLOR VISION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; ELECTRORETINOGRAM; ERECTILE DYSFUNCTION; HUMAN; ISCHEMIC OPTIC NEUROPATHY; NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY; PHOTOSENSITIVITY; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SIDE EFFECT; SYMPTOMATOLOGY; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

ANIMALS; ARTERIES; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; ERECTILE DYSFUNCTION; HUMANS; MALE; OPTIC NEUROPATHY, ISCHEMIC; PHOSPHODIESTERASE INHIBITORS;

EID: 55849144351     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/ijir.2008.25     Document Type: Review

References (54)

1. Fink HA, MacDonald R, Rutks IR, Nelson DB, Wilt TJ. Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 2002; 162: 1349-1360.
2. Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8: 47-52.
3. McVary KT. Erectile dysfunction. N Engl J Med 2007; 357: 2472-2481.
4. Marmor MF, Kessler R. Sildenafil (Viagra) and ophthalmology. Surv Ophthalmol 1999; 44: 153-162.
5. Laties A, Zrenner E. Viagra (sildenafil citrate) and ophthalmology. Prog Retin Eye Res 2002; 21: 485-506.
6. Cote RH. Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5. Int J Impot Res 2004; 16(Supp 1): S28-S33.
7. Jägle H, Jägle C, Sérey L, Yu A, Rilk A, Sadowski B et al. Visual short-term effects of Viagra: double-blind study in healthy young subjects. Am J Ophthalmol 2004; 137: 842-849.
8. Luu JK, Chappelow AV, McCulley TJ, Marmor MF. Acute effects of sildenafil on the electroretinogram and multifocal electroretinogram. Am J Ophthalmol 2001; 132: 388-394.
9. McCulley TJ, Lam BL, Marmor MF, Hoffman KB, Luu JK, Feuer WJ. Acute effects of sildenafil (Viagra) on blue-on-yellow and white-on-white Humphrey perimetry. J Neuroophthalmol 2000; 20: 227-228.
10. Ermis SS, Inan UU, Samli M, Ozturk F. Acute effects of sildenafil on Humphrey visual field and intraocular pressure. Int Ophthalmol 2004; 25: 69-72.
11. Oner HF, Aslan G, Kurtulan E, Uçar T, Saatçi OA, Esen AA. Effect of sildenafil citrate on retinal functions: preliminary report on Humphrey visual field analysis. Urol Int 2004; 73: 28-30.
12. Dryja TP, Rucinski DE, Chen SH, Berson EL. Frequency of mutations in the gene encoding the alpha subunit of rod cGMP-phosphodiesterase in autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci 1999; 40: 1859-1865.
13. Behn D, Potter MJ. Sildenafil-mediated reduction in retinal function in heterozygous mice lacking the γ-subunit of phosphodiesterase. Invest Ophthalmol Vis Sci 2001; 42: 523-527.
14. Rucker JC, Biousse V, Newman NJ. Ischemic optic neuropathies. Curr Opin Neurol 2004; 17: 27-35.
15. Johnson LN, Arnold AC. Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California. J Neuroophthalmol 1994; 14: 38-44.
16. Hattenhauer MG, Leavitt JA, Hodge DO, Grill R, Gray DT. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1997; 123: 103-107.
17. Hayreh SS. Anterior ischaemic optic neuropathy: differentiation of arteritic from non-arteritic type and its management. Eye 1990; 4: 25-41.
18. Ischemic Optic Neuropathy Decompression Trial Research Group. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the ischemic optic neuropathy decompression trial. Arch Ophthalmol 1996; 114: 1366-1374.
19. Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 2003; 23: 157-163.
20. Hayreh SS, Podhajsky PA, Zimmerman B. Non-arteritic anterior ischemic optic neuropathy: time of onset of visual loss. Am J Ophthalmol 1997; 124: 641-647.
21. Hayreh SS, Zimmerman MB, Podhajsky PA, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994; 117: 603-624.
22. Beck RW, Servais GE, Hayreh SS. Anterior ischemic optic neuropathy. IX. Cup-to-disc ratio and its role in pathogenesis. Ophthalmology 1987; 94: 1503-1508.
23. Chi T, Ritch R, Stickler D, Pitman B, Tsai C, Hsieh FY. Racial differences in optic nerve head parameters. Arch Ophthalmol 1989; 107: 836-839.
24. Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 1995; 273: 625-632.
25. Newman NJ, Scherer R, Langenberg P, Kelman S, Feldon S, Kaufman D, et al., Ischemic Optic Neuropathy Decompression Trial Research Group. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002; 134: 317-328.
26. Cunningham AV, Smith KH. Anterior ischemic optic neuropathy associated with Viagra. J Neuroophthalmol 2001; 21: 22-25.
27. Pomeranz HD, Smith KH, Hart WM, Egan RA. Sildenafil-associated nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2002; 109: 584-587.
28. Dheer S, Rekhi GS, Merlyn S. Sildenafil associated anterior ischemic optic neuropathy. J Assoc Physicians India 2002; 50: 265.
29. Boshier A, Pambakian N, Shakir SA. A case of nonarteritic ischemic optic neuropathy (NAION) in a male patient taking sildenafil. Int J Clin Pharmacol Ther 2002; 40: 422-423.
30. Gruhn N, Fledelius HC. Unilateral optic neuropathy associated with sildenafil intake. Acta Ophthalmol Scand 2005; 83: 131-132.
31. Sinha S, Pathak-Ray V, Ahluwalia H, Morgan JE. Viagra or what? Eye 2004; 18: 446-448.
32. Pomeranz HD, Bhavsar AR. Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (Viagra): a report of seven new cases. J Neuroophthalmol 2005; 25: 9-13.
33. Escaravage Jr GK, Wright JD, Givre SJ. Tadalafil associated with anterior ischemic optic neuropathy. Arch Ophthalmol 2005; 123: 399-400.
34. Bollinger K, Lee MS. Recurrent visual field defect and ischemic optic neuropathy associated with tadalafil rechallenge. Arch Ophthalmol 2005; 123: 400-401.
35. Peter NM, Singh MV, Fox PD. Tadalafil-associated anterior ischaemic optic neuropathy. Eye 2005; 19: 715-717.
36. Akash R, Hrishikesh D, Amith P, Sabah S. Case report: association of combined nonarteritic anterior ischemic optic neuropathy (NAION) and obstruction of cilioretinal artery with overdose of Viagra. J Ocul Pharmacol Ther 2005; 21: 315-317.
37. Gedik S, Yilmaz G, Akova YA. Sildenafil-associated consecutive nonarteritic anterior ischemic optic neuropathy, cilioretinal artery occlusion, and central retinal vein occlusion in a hemodialysis patient. Eye 2007; 21: 129-130.
38. Sivaswamy L, Vanstavern GP. Ischemic optic neuropathy in a child. Pediatr Neurol 2007; 37: 371-372.
39. Sowka JW, Neiberg MN, Vollmer LA. Optic atrophy after sildenafil use. Optometry 2007; 78: 122-128.
40. Pepin S, Pitha-Rowe I. Stepwise decline in visual field after serial sildenafil use. J Neuroophthalmol 2008; 28: 76-77.
41. McGwin Jr G, Vaphiades MS, Hall TA, Owsley C. Non-arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction. Br J Ophthalmol 2006; 90: 154-157.
42. Sobel RE, Cappelleri JC. NAION and treatment of erectile dysfunction: reply from Pfizer. Br J Ophthalmol 2006; 90: 927.
43. Danesh-Meyer HV, Levin LA. Erectile dysfunction drugs and risk of anterior ischaemic optic neuropathy: casual or causal association? Br J Ophthalmol 2007; 91: 1551-1555.
44. Margo CE, French DD. Ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors. Am J Ophthalmol 2007; 143: 538-539.
45. Reffelmann T, Kloner RA. Cardiovascular effects of phosphodiesterase 5 inhibitors. Curr Pharm Des 2006; 12: 3485-3494.
46. Hayreh SS. Erectile dysfunction drugs and non-arteritic anterior ischemic optic neuropathy: is there a cause and effect relationship. J Neuroophthalmol 2005; 25: 295-298.
47. Pomeranz HD. Can erectile dysfunction drug use lead to ischaemic optic neuropathy? Br J Ophthalmol 2006; 90: 127-128.
48. Grunwald JE, Siu KK, Jacob SS, Dupont J. Effect of sildenafil citrate (Viagra) on the ocular circulation. Am J Ophthalmol 2001; 131: 751-755.
49. Hayreh SS. Comment on: effect of sildenafil citrate (Viagra) on the ocular circulation. Am J Ophthalmol 2002; 133: 169-170.
50. Petrig BL, Riva CE, Hayreh SS. Laser Doppler flowmetry and optic nerve head blood flow. Am J Ophthalmol 1999; 127: 413-425.
51. Gorkin L, Hvidsten K, Sobel RE, Siegel R. Sildenafil citrate use and the incidence of nonarteritic ischemic optic neuropathy. Int J Clin Pract 2006; 60: 500-503.
52. Hatzimouratidis K, Hatzichristou D. Phosphodiesterase type 5 inhibitors: the day after. Eur Urol 2007; 51: 75-88.
53. http://www.fda.gov/cder/drug/InfoSheets/HCP/sildenafilHCP.htm.
54. Carter JE. Anterior ischemic optic neuropathy and stroke with use of PDE-5 inhibitors for erectile dysfunction: cause or coincidence? J Neurol Sci 2007; 262: 89-97.